2Invest AG is a Germany-based publicly listed investment holding company, formerly known as 4Basebio AG, focused on acquiring, holding, managing, and divesting stakes in corporations and partnerships worldwide. Its primary purpose is to strategically deploy capital into high-growth opportunities across diverse sectors, including biotechnology, life sciences, information technology, natural resources, and select traditional industries, to optimize portfolio value and shareholder returns through disciplined investment processes. Notable features include a diversified portfolio with holdings such as 4Basebio PLC in biotechnology and various resource companies like Spartan Resources Limited and Theta Gold Mines Limited, alongside a lean operation with just 3-5 employees headquartered in Heidelberg. Led by CEO Hansjörg Plaggemars and Chairman Rainer Herschlein, 2Invest AG navigates global markets to identify emerging trends, mitigate risks via diversification, and support innovation in dynamic sectors. In the financial markets, it serves as a vehicle for indirect exposure to specialized industries, channeling investments into promising businesses while contributing to economic development through active portfolio management.